Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia.
<h4>Background</h4>Multi-nucleos(t)ide resistance (MNR) mutations including Q151M, K65R mutations, and insertion at codon 69 of HIV-1 reverse transcriptase coding region may confer resistance to all molecules of nucleos(t)ide reverse transcriptase inhibitors (NRTI). The presence of these...
Guardado en:
Autores principales: | Janin Nouhin, Yoann Madec, Nicole Ngo-Giang-Huong, Laurent Ferradini, Eric Nerrienet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/36d6003aad2f41c4a842e45911a9c53c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.
por: Mar Pujades-Rodríguez, et al.
Publicado: (2011) -
Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment.
por: Thong Phe, et al.
Publicado: (2013) -
Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.
por: Romain Micol, et al.
Publicado: (2010) -
Acta No. 151
por: Banco Central de Chile
Publicado: (2019) -
Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial).
por: Laurence Borand, et al.
Publicado: (2014)